Amcinonide AMCINONIDE SUN PHARMACEUTICAL INDUSTRIES, INC. FDA Approved The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. TOPICAL CREAM USP, 0.1% Each gram of Amcinonide Cream contains 1 mg of the active steroid amcinonide in a white, smooth, homogeneous, opaque emulsion composed of benzyl alcohol (as preservative), emulsifying wax, glycerin, isopropyl palmitate, lactic acid, purified water and sorbitol solution 70%. TOPICAL OINTMENT USP, 0.1% Each gram of Amcinonide Ointment contains 1 mg of the active steroid amcinonide in a specially formulated base composed of benzyl alcohol 2.2% (wt/wt) as preservative, butylated hydroxyanisole, citric acid anhydrous, emulsifying wax, propyl gallate, propylene glycol, and white petrolatum. Chemically, amcinonide is: Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis (oxy)]-9-fluoro-11-hydroxy-, (11β, 16α). Chemical Structure

Drug Facts

Composition & Profile

Strengths
0.1 % 1 mg/g
Quantities
2 count
Treats Conditions
Indications And Usage Topical Corticosteroids Are Indicated For The Relief Of The Inflammatory And Pruritic Manifestations Of Corticosteroid Responsive Dermatoses

Identifiers & Packaging

Container Type BOX
UNII
423W026MA9
Packaging

HOW SUPPLIED Amcinonide Topical Cream USP, 0.1% (1 mg/g) is supplied in 4 gm, 15 gm, 30 gm and 60 gm tubes. Amcinonide Topical Ointment USP, 0.1% (1 mg/g) is supplied in 15 gm, 30 gm and 60 gm tubes. Store at 20° -25°C (68°-77°F) [see USP Controlled Room Temperature] DO NOT FREEZE.; PRINCIPAL DISPLAY PANEL - 30 g Tube Carton NDC 51672-4054-2 30 g Amcinonide Cream USP, 0.1% FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. Rx only TARO Keep this and all medications out of the reach of children. PRINCIPAL DISPLAY PANEL - 30 g Tube Carton; PRINCIPAL DISPLAY PANEL - 30 g Tube Carton NDC 51672-4060-2 30 g Amcinonide Ointment USP, 0.1% FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. Rx only TARO Keep this and all medications out of the reach of children. PRINCIPAL DISPLAY PANEL - 30 g Tube Carton

Package Descriptions
  • HOW SUPPLIED Amcinonide Topical Cream USP, 0.1% (1 mg/g) is supplied in 4 gm, 15 gm, 30 gm and 60 gm tubes. Amcinonide Topical Ointment USP, 0.1% (1 mg/g) is supplied in 15 gm, 30 gm and 60 gm tubes. Store at 20° -25°C (68°-77°F) [see USP Controlled Room Temperature] DO NOT FREEZE.
  • PRINCIPAL DISPLAY PANEL - 30 g Tube Carton NDC 51672-4054-2 30 g Amcinonide Cream USP, 0.1% FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. Rx only TARO Keep this and all medications out of the reach of children. PRINCIPAL DISPLAY PANEL - 30 g Tube Carton
  • PRINCIPAL DISPLAY PANEL - 30 g Tube Carton NDC 51672-4060-2 30 g Amcinonide Ointment USP, 0.1% FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. Rx only TARO Keep this and all medications out of the reach of children. PRINCIPAL DISPLAY PANEL - 30 g Tube Carton

Overview

The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. TOPICAL CREAM USP, 0.1% Each gram of Amcinonide Cream contains 1 mg of the active steroid amcinonide in a white, smooth, homogeneous, opaque emulsion composed of benzyl alcohol (as preservative), emulsifying wax, glycerin, isopropyl palmitate, lactic acid, purified water and sorbitol solution 70%. TOPICAL OINTMENT USP, 0.1% Each gram of Amcinonide Ointment contains 1 mg of the active steroid amcinonide in a specially formulated base composed of benzyl alcohol 2.2% (wt/wt) as preservative, butylated hydroxyanisole, citric acid anhydrous, emulsifying wax, propyl gallate, propylene glycol, and white petrolatum. Chemically, amcinonide is: Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis (oxy)]-9-fluoro-11-hydroxy-, (11β, 16α). Chemical Structure

Indications & Usage

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

Topical corticosteroids are generally applied to the affected area as a thin film from two to three times daily depending on the severity of the condition. Occlusive dressings may be a valuable therapeutic adjunct for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Warnings & Precautions
No warnings available yet.
Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria

Storage & Handling

Store at 20° -25°C (68°-77°F) [see USP Controlled Room Temperature] DO NOT FREEZE.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →